The IBI group led by Ferran Sanz and Laura I. Furlong, promotes and tackles synergistic and integrative strategies for facing biomedical problems by making use of approaches developed at the IBI group and by fostering the collaboration between research groups of the GRIB.
Currently, an increasing wealth of information, particularly the one generated by biomedical research, is left unused. There is a great difficulty in both the identification and use of clinically actionable information. The goal of our group is to develop methods and tools to help to solve this problem, with a special focus in methods that promote an understanding of human health and disease.
The current research lines of the Integrative Biomedical Informatics are:
- Development of new strategies and tools for knowledge extraction from biomedical literature and other publicly available sources.
- Network biology for the study of human diseases and drug toxicity
- Integrative knowledge management and exploitation in drug discovery and development, including multi-level and multi-scale modelling and simulation.